INTERNATIONAL PATENT: SHENZHEN FORWARD PHARMACEUTICALS CO., LIMITED, 深圳福沃药业有限公司 FILES APPLICATION FOR "QUINAZOLINE DERIVATIVE AS KRAS MUTATION INHIBITOR FOR TREATMENT OF CANCER"

GENEVA, Dec. 21 -- SHENZHEN FORWARD PHARMACEUTICALS CO., LIMITED (B302, 19 Gaoxin S. 7th Ave., Nanshan DistrictShenzhen, Guangdong 518067), 深圳福沃药业有限公司 (中国广东省深圳市南山区高新南七道19号B302) filed a patent application (PCT/CN2025/100723) for "QUINAZOLINE DERIVATIVE AS KRAS MUTATION INHIBITOR FOR TREATMENT OF CANCER" on Jun 12, 2025. With publication no. WO/2025/256599, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...